14 January 2011
Smiths Group confirms that it has received an approach for Smiths Medical which it has rejected.
The value offered was £2.45 billion in cash, as a best and final offer, subject inter alia, to extensive due diligence and completion of financing.
The Board has carefully considered this approach with its advisers and has concluded that it would not be in the interests of shareholders to pursue discussions on the basis of an indication at this price level.
In reaching this conclusion, the Board has taken into account the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:

Please note – the press team can only answer enquiries from accredited members of the press.
Related articles

Smiths Detection sets new standard with future-proof hold baggage and air cargo screening solution
Read our latest company news as Smiths Detection launches new hold baggage and air cargo screening solution.
Find out more
Annual Results for the year ended 31 July 2025
Find out more
Smiths Detection selected as security technology provider to International Airport Heraklion Crete
Read our latest company news as Smiths Detection announces selection to supply a suite of leading security screening solutions to International Airport Heraklion Crete
Find out more